Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...

While SpaceX led the way in revolutionizing the commercial launch business, a new wave of companies is vying to supply the ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended ...

Amazon is removing a key privacy feature from its Echo smart speakers that one tech expert has called ‘absolutely ...